Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Aptose Biosciences Inc (APS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.71 -0.07    -2.52%
22/10 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
ISIN:  CA03835T2002 
S/N:  03835T200
  • Volume: 1,400
  • Bid/Ask: 2.70 / 2.72
  • Day's Range: 2.66 - 2.71
Aptose Biosciences 2.71 -0.07 -2.52%
Name Company Industry
   
P/E Ratio TTM - 108.36
Price to Sales TTM - 3,286.66
Price to Cash Flow MRQ - 36.52
Price to Free Cash Flow TTM - 60.85
Price to Book MRQ 1.96 5.15
Price to Tangible Book MRQ 1.96 11.3
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM - 58.44
Gross Margin 5YA - 36.38
Operating margin TTM - -23,803.68
Operating margin 5YA - -2,998.56
Pretax margin TTM - -38,137.45
Pretax margin 5YA - -2,990.96
Net Profit margin TTM - -38,147.51
Net Profit margin 5YA - -2,991.84
   
Revenue/Share TTM - 27.18
Basic EPS ANN -0.83 0.83
Diluted EPS ANN -0.83 0.8
Book Value/Share MRQ 1.37 13.13
Tangible Book Value/Share MRQ 1.37 -2.08
Cash/Share MRQ 1.44 0.95
Cash Flow/Share TTM -0.81 3
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM -65% -9.38
Return on Equity 5YA -71.05% -31.31
Return on Assets TTM -60.21% -13.54
Return on Assets 5YA -65.28% -11.91
Return on Investment TTM -64.6% -18.08
Return on Investment 5YA -70.58% -26.74
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 26.66% -107.56
EPS(TTM) vs TTM 1 Yr. Ago TTM -6.75% -11.66
5 Year EPS Growth 5YA - -22.05
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ - 55.04
Sales (TTM) vs TTM 1 Yr. Ago TTM - 179.65
5 Year Sales Growth 5YA - -6.85
5 Year Capital Spending Growth 5YA -21.08% 12.64
   
Quick Ratio MRQ - 1.05
Current Ratio MRQ 13.67 4.45
LT Debt to Equity MRQ 0% 55.16
Total Debt to Equity MRQ 0% 61.81
Efficiency    
Asset Turnover TTM - 0.76
Inventory Turnover TTM - 26.5
Revenue/Employee TTM - 105.70K
Net Income/Employee TTM -1.83M -249.49K
Receivable Turnover TTM - 10.8
   
Dividend Yield ANN - 1.16
Dividend Yield 5 Year Avg. 5YA - 1.49
Dividend Growth Rate ANN - -5.63
Payout Ratio TTM - 12.11
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

APS Comments

Write your thoughts about Aptose Biosciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ma Ah
Ma Ah Jul 22, 2021 10:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any thoughts on this?
Liew ST
Liew ST Jun 15, 2021 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2021.06.14. Bought again @ 3.81 after the dive.
Liew ST
Liew ST Jun 08, 2021 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2021.06.08. Bought 3.80 and sold 6.80 in March 2021
la la
la la Mar 31, 2021 5:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target at about 11.40$
Mke Gee
Mke Gee Mar 29, 2021 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
100% BUY! Check it out!
Mke Gee
Mke Gee Mar 29, 2021 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
U wouldve made 5.78% on your money!
Anthony Gautier
Anthony Gautier Dec 18, 2020 2:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Encouraging newsChairman, President and Chief Executive Officer. “We are encouraged by the continued increase in plasma exposure, and we hope the current and future dose levels will deliver formal responses to these deeply relapsed or refractory CLL patients. In AML, we are pleased by the observation of an anti-leukemic blast reduction from 93% to 10% in one of our first patients who was heavily pretreated with several consecutive FLT3 inhibitors. For APTO-253, we continue to escalate the dose and observe MYC repression, suggesting future potential for broad anti-cancer activity. We are pleased by such indicators of activity from both CG-806 and APTO-253, and we look forward to providing further updates in the first half of 2021 and at the Annual EHA Meeting 2021.”
Anthony Gautier
Anthony Gautier Dec 16, 2020 12:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
APTO is a LT Stock, I see good things ahead as they get positive results from their studies..I have a good feeling about it, loaded up for LT at this price range
Sky Emperor
SkyEmperor Dec 15, 2020 9:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I got in at 3.98, lets see how will it go
Sky Emperor
SkyEmperor Nov 13, 2020 3:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is time to buy?
Longino Ojeda Sánchez
Longino Ojeda Sánchez Nov 13, 2020 3:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wait
James Kiz
James Kiz Nov 13, 2020 3:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
if you are interstates
Mark Ranger
Mark Ranger Dec 09, 2019 11:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BUY BUY BUY
Jeff Lakatos
Jeff Lakatos Feb 09, 2017 11:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello? Anybody out there? I bought this at $1.00 after it was announced they were going to stop working on one drug and switching focus to another which brought price way down.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email